| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
6,804 |
5,293 |
$316K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
3,928 |
3,440 |
$314K |
| 99396 |
Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years |
783 |
735 |
$64K |
| 99395 |
Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years |
484 |
459 |
$40K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
1,898 |
1,687 |
$12K |
| 96127 |
|
572 |
492 |
$10K |
| 90686 |
|
216 |
151 |
$4K |
| 90674 |
|
77 |
39 |
$2K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
69 |
47 |
$1K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
15 |
12 |
$1K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
64 |
53 |
$817.36 |
| 81002 |
|
238 |
225 |
$616.20 |
| 92250 |
|
13 |
13 |
$577.20 |
| 0011A |
|
12 |
12 |
$505.68 |
| 90656 |
|
18 |
12 |
$366.57 |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
14 |
13 |
$328.44 |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
15 |
13 |
$219.80 |
| J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg |
22 |
12 |
$55.28 |
| 99072 |
|
49 |
39 |
$0.00 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
40 |
28 |
$0.00 |